COMBINATION THERAPY FOR TREATING CYCLOOXYGENASE-2 MEDIATED DISEASES IN PATIENTS AT RISK OF THROMBOTIC CARDIOVASCULAR EVENTS - Patent 1505985

(19)

(11)

EP 1 505 985 A1

(12)

(43)	Date of publication:
	16.02.2005 Bulletin 2005/07

(21)	Application number: 03726785.3

(22)	Date of filing: 09.05.2003

(51)	International Patent Classification (IPC)⁷: A61K 31/60, A61K 31/50, A61K 31/4418, A61K 31/42, A61K 31/415, A61K 31/341, A61K 31/196

(86)	International application number:
	PCT/US2003/014778

(87)	International publication number:
	WO 2003/094924 (20.11.2003 Gazette 2003/47)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
	Designated Extension States:
	AL LT LV MK

(30)

Priority:

10.05.2002 US 388660 P

(71)	Applicant: Merck & Co., Inc.
	Rahway,New Jersey 07065-0907 (US)

(72)	Inventors:
	HUNT, Richard, H. Rahway, NJ 07065-0907 (US) SIMON, Thomas, J. Rahway, NJ 07065-0907 (US)

(74)	Representative: Buchan, Gavin MacNicol
	Merck & Co., Inc.,European Patent Department,Terlings Park,Eastwick Road Harlow,Essex CM20 2QR Harlow,Essex CM20 2QR (GB)

(54)	COMBINATION THERAPY FOR TREATING CYCLOOXYGENASE-2 MEDIATED DISEASES IN PATIENTS AT RISK OF THROMBOTIC CARDIOVASCULAR EVENTS